Aclaris Therapeutics, Inc. Intellectual Property Contracts & Agreements
3 Contracts & Agreements
- License Agreements (3 contracts)
- Exclusive Patent License Agreement, by and between the Company and Allergan, Inc., dated as of November 30, 2018 (Filed With SEC on December 3, 2018)
- First Amendment to License Agreement, by and between The Trustees of Columbia University in the City of New York and the Registrant, dated as of June 27, 2018 (Filed With SEC on August 3, 2018)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on May 11, 2016)
